PRIA Logo™
119-hr-8192119th CongressWALLET

Nitazene Response Act

Sponsored By: Representative Taylor, David J. [R-OH-2]

Introduced

Summary

Creates federal clinical guidance to respond to nitazene overdoses. This bill would require the Secretary of Health and Human Services to publish updated, evidence-based clinical guidelines for treating overdoses involving nitazenes and other ultra-potent synthetic opioids. The guidance must cover naloxone administration protocols and recommendations for emergency departments, hospitals, and rural and volunteer emergency medical services, be posted on the HHS website within 180 days, and a report with the guidelines must be delivered to Congress within one year. The bill defines nitazenes and lists examples such as etonitazene, isotonitazene, and protonitazene.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

New federal nitazene overdose guidance

This bill would require HHS to issue evidence-based clinical guidelines for nitazene overdoses. HHS would publish the guidelines on its public website within 180 days of enactment. The guidelines would cover naloxone use, emergency department and hospital care, and guidance for rural and volunteer EMS. HHS would send a report to Congress with the guidelines and how they will help within one year. The bill would also define "nitazene" and "nitazene overdose" so responders know which drugs are covered.

Sponsors & CoSponsors

Sponsor

Taylor, David J. [R-OH-2]

OH • R

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation